M3 India

show all contributors

Dr. Kumar Prabhash

is Professor, Medical Oncology at Tata Memorial Hospital with more than two decades of experience

Dr. Kumar Prabhash is Professor, Medical Oncology at Tata Memorial Hospital and has more than two decades of experience in this field. He has published over a hundred research and review articles/papers in journals of national and international repute.

Talks

Articles

Originals

Deriving the most effective metronomic dose of methotrexate for advanced oral cancer: Dr. Kumar Prabhash

Triple oral metronomic chemotherapy with e... more»Triple oral metronomic chemotherapy with erlotinib, methotrexate, and celecoxib is efficacious in platinum-refractory oral cavity cancers and represents a new therapeutic option in patients with poor prognosis. «less

Oct 18, 2019

Originals

Dr Kumar Prabhash's commentary: Gefitinib vs. Gefitinib plus Pemetrexed and Carboplatin chemotherapy in EGFR-Mutated lung cancer

A clinical study by Dr. Kumar Prabhash and... more»A clinical study by Dr. Kumar Prabhash and his team was published in JCO in the month of August 2019 which concluded that adding pemetrexed and carboplatin chemotherapy to gefitinib significantly prolonged PFS and OS but increased toxicity in patients with NSCLC. «less

Aug 20, 2019